Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446446
Status:
COMPLETED
Last Update Posted:
2022-10-05
First Post:
2007-03-08
Brief Title:
PRISM Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer
Sponsor:
Organization:
Amgen